SummaryRMgm-339
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene tagging |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 20478340 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | S. Déchamps; K. Wengelnik; H.J. Vial; L. Gannoun-Zaki |
Name Group/Department | Dynamique des Interactions Membranaires Normales et Pathologiques |
Name Institute | Université Montpellier |
City | Montpellier |
Country | France |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-339 |
Principal name | CCT-GFP |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | No |
top of page | |
Phenotype | |
Asexual blood stage | Western analysis using GFP-antibodies and fluorescence microscopy showed (low) CCT-GFP expression in (the cytoplasm of) blood stages. |
Gametocyte/Gamete | Not tested |
Fertilization and ookinete | Not tested |
Oocyst | Not tested |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation P. berghei CCT and ECT contain the signature sequence of the cytidylyltransferase family, RxxG(V/I)STT, the CTP binding site HxGH, and the lysine residues involved in P-Cho and in Etn binding. This indicates that PbCCT and PbECT can be expected to carry phosphocholine and phosphoethanolamine transferase activities, respectively. An additional route termed serine decarboxylation-phosphoethanolamine methylation (SDPM) pathway has been identified in P. falciparum. In this plant-like pathway that connects different routes, the polar head groups of PE and PC are synthesized from serine that is either directly imported from the host or obtained through degradation of host cell haemoglobin. However, phosphoethanolamine N80 methyltransferase (PMT) activity is absent from P. berghei and an ortholog to the P. falciparum pmt gene (MAL13P1.214) could not be identified in the genome of P. berghei and other rodent malaria parasites.
FIG 1. Biosynthesis pathways for PC, PE and PS in Plasmodium. Other mutants |
top of page | |||||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1415100 | ||||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1316600 | ||||||||||||||||||||||||||
Gene product | choline-phosphate cytidylyltransferase | ||||||||||||||||||||||||||
Gene product: Alternative name | CCT | ||||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||||
Name of the tag | GFP-mutant3 | ||||||||||||||||||||||||||
Details of tagging | C-terminal | ||||||||||||||||||||||||||
Additional remarks: tagging | |||||||||||||||||||||||||||
Commercial source of tag-antibodies | |||||||||||||||||||||||||||
Type of plasmid/construct | Plasmid single cross-over | ||||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||||
Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||||
Additional remarks genetic modification | The single cross-over event result in replacement of the endogenous gene with a cct gene fused to a gfp-tag at the C-terminus. For the generation of the GFP-tagging construct, the 3′ end of the Pbcct (1485 bp, nucleotides 1251-2735) coding region, omitting the stop codon, was amplified by PCR from P. berghei genomic DNA with the forward and reverse primers: p13/p14. Vector pDR-CCT-GFP was generated by introducing the obtained fragment, using restriction sites ApaI/ApaI, into the pDR009 plasmid. | ||||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
top of page |